It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
In 2005, Jeff Sharlet claimed that while New Life is "by no means the largest megachurch…[it] holds more sway over the political direction of evangelicalism" than any other church in America.
In 1986, the Cultic Studies Journal published Laurie Jacobson's account of her experiences within YWAM. In it Jacobson depicts a Discipleship Training School program of eisegesis and social engineering designed to inculcate attitudes and obtain conformity to the group's ways.  Evangelical theologians Alan Gomes and E. Calvin Beisner claim that certain unorthodox doctrines were taught at some YWAM locations from the 1970s until the 1990s. In 1990, researcher Rick Ross, retained by a family in Long Island, New York, published an evaluation of YWAM, refusing to recommend them. Ross' research not only included an interview with the YWAM leaders but also was founded on information obtained from Christian Research Institute, the pre-Scientology Cult Awareness Network, the book Spiritual Warfare by Sara Diamond, and further mention of YWAM in Charisma Magazine. In the report he cited their failure on the basis of Robert J. Lifton's eight criteria for recognizing thought reform and mind control. The Miami Herald also published criticism of YWAM by Baptist missionary LaToya Channer from her experiences up to January 1992, when she left the organization. Channer described the organization to reporter Aurin Squire as a "cult" to which she "became dependent." The Wellington New Zealand Star-Times also examined politician Bernie Ogilvy's connection to the organization during this time period. In the report, Ogilvy confirmed that the group has been called a "cult" by overseas sceptics but said that impression had been corrected. The Star-Times reported that YWAM made enough money to buy up to 12 Auckland houses and that Ogilvy at one point lived in a large house with a swimming pool as the National Director. Ogilvy stated that the houses were all sold and the money given away.
Originally posted by DocMoreau
... where did he get all the firearms and ammunition?
54 1/2 alprazolam pills, an anti-anxiety drug
Alprazolam, also known under the trade names Xanax and Niravam, is a short-acting drug in the benzodiazepine class used to treat severe anxiety disorders and as an adjunctive treatment for anxiety associated with clinical depression.
Sheehan describes that the first group of patients treated by alprazolam was so impressed by its action that they knew outright—this drug was going to be a hit. A few of them pooled their money and bought the Upjohn’s stock. Several months later, when alprazolam was approved by the FDA, they sold out and made a profit.
Alprazolam is FDA-approved for the short term treatment (up to 8 weeks) of panic disorder, with or without agoraphobia. Alprazolam is very effective in preventing moderate to severe anxiety, essential tremor, panic attacks and other types of convulsive behaviors.
Alprazolam is recommended for the short-term treatment (2-4 weeks) of severe acute anxiety. Alprazolam should only very rarely be used for longer periods of time -- the body becomes rapidly tolerant to the drug's effects, which may translate to decreased efficacy. Decreased efficacy can lead to dose escalation, and the use of high doses puts the patient at higher risk for withdrawal if the drug is discontinued suddenly.
decreased inhibitions, no fear of danger (increased risk taking behavior)
depressed mood with thoughts of suicide or self harm
hallucinations, agitation and hostility
feeling dizziness, light headed or fainting
urinating less than usual or not at all
headache, fatigue, joint pain and unusual weakness (flu like symptoms)
complete memory loss, (amnesia) and concentration problems
changes in appetite (including changes in weight)
blurred vision, unsteadiness and clumsiness (impaired coordination and balance)
constipation, diarrhea, nausea and vomiting
decreased sex drive
dry mouth or increased salivation
nervousness, restlessness, sleeplessness and sweating
pounding in the chest or rapid heartbeat
muscle twitching, tremor and seizure (convulsions)
There is now a general consensus among psychiatrists that alprazolam and other benzodiazepines can cause withdrawal symptoms after long-term treatment and discontinuation should be done gradually over a period of months (or even up to a year) to avoid serious withdrawal symptoms such as agitation, panic attacks, rebound anxiety, muscle cramps and seizures.
Alprazolam has an exceptional history insofar soon after its introduction a large number of case reports were published in the medical literature of severe withdrawal symptoms related case reports of withdrawal psychoses, seizures and intense rebound anxiety upon discontinuation of alprazolam. In the United States a survey of physicians showed that 84% of physicians reported alprazolam as being extremely problematic in terms of the severity and prolonged nature of the benzodiazepine withdrawal syndrome after discontinuation. The benzodiazepines diazepam (Valium) and oxazepam were found to produce less severe withdrawal symptoms than alprazolam (Xanax) or lorazepam (Ativan).
Alprazolam should never be abruptly discontinued if taken regularly for any length of time because severe withdrawal symptoms may occur. Severe psychosis has been reported in the medical literature from abrupt alprazolam withdrawal and death occurred from withdrawal-related seizures after gradual dose reduction, which suggests that alprazolam when being discontinued should be done so very slowly over a prolonged period of time to avoid severe withdrawal symptoms.